Patent details
EP1689751 Title: 5,7-DIAMINOPYRAZOLOÖ4,3-DÜPYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY
Basic Information
- Publication number:
- EP1689751
- PCT Application Number:
- PCT/IB/2004/003747
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP047988761
- PCT Publication Number:
- WO/2005/049616
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 5,7-DIAMINOPYRAZOLOÖ4,3-DÜPYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY
- French Title of Invention:
- 5,7-DIAMINOPYRAZOLOÖ4,3-DÜPYRIMIDINES A EFFET INHIBITEUR PAR RAPPORT A LA PDE-5
- German Title of Invention:
- 5,7-DIAMINOPYRAZOLOÖ4,3-DÜPYRIMIDINE MIT PDE-5-HEMMENDER WIRKUNG
- SPC Number:
Dates
- Filing date:
- 12/11/2004
- Grant date:
- 20/10/2010
- EP Publication Date:
- 20/10/2010
- PCT Publication Date:
- 02/06/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/08/2006
- EP B1 Publication Date:
- 20/10/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/11/2018
- Expiration date:
- 12/11/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/11/2004
- Name:
- Pfizer Inc.
- Address:
- 235 East 42nd Street, New York, NY 10017, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 20/10/2010
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- FOX David Nathan A., Pfizer Global R&D
- Address:
- United Kingdom (GB)
2
- Name:
- BELL Andrew Simon, Pfizer Global R&D
- Address:
- United Kingdom (GB)
3
- Name:
- DACK Kevin Neil, Pfizer Global R&D
- Address:
- United Kingdom (GB)
4
- Name:
- MARSH Ian Roger, Pfizer Global R&D
- Address:
- United Kingdom (GB)
5
- Name:
- BROWN David Graham, Pfizer Global R&D
- Address:
- United Kingdom (GB)
6
- Name:
- WINSLOW Carol Ann, Pfizer Global R&D
- Address:
- United Kingdom (GB)
7
- Name:
- PALMER Michael John, Pfizer Global R&D
- Address:
- United Kingdom (GB)
8
- Name:
- MORRELL Andrew Ian, Pfizer Global R&D
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0327319
- Priority Date:
- 24/11/2003
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- C07D 487/04;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 02/11/2017
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 198 Euro
- Payer:
- MDC (HENKEL PATENT)
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/03/2019 | Outgoing Correspondence | 1 |